Yam-Hong Wong1, MBBS, MRCP(UK), FHKCP, FHKAM; Ole De Backer1, MD, PhD; Lars Søndergaard1, MD, DMSc; Gintautas Bieliauskas1, MD
1. The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Figure 1. Percutaneous management of an embolised MANTA. A) & B) Working mechanism of the MANTA closure device. C) The embolised device and the active contrast extravasation from the arteriotomy wound. D) The further embolised device and successful haemostasis. E) The stabilised device with minimal residual stenosis.
A 74-year-old female with severe aortic valve stenosis was offered transfemoral transcatheter aortic valve implantation (TAVI) due to comorbidities and surgical risks. After an uneventful TAVI, closure of the right femoral arteriotomy was attempted with an 18 Fr MANTA™ vascular closure device (Essential Medical Inc., Exton, PA, USA). This novel closure device ...
